Literature DB >> 10406396

ApoE genotype and protease-inhibitor-associated hyperlipidaemia.

G Behrens, H H Schmidt, M Stoll, R E Schmidt.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10406396     DOI: 10.1016/S0140-6736(05)75347-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors.

Authors:  Madhu N Rao; Grace A Lee; Carl Grunfeld
Journal:  Am J Infect Dis       Date:  2006-09-30

Review 2.  The effects of HIV protease inhibitors on carbohydrate and lipid metabolism.

Authors:  Grace A Lee; Madhu N Rao; Carl Grunfeld
Journal:  Curr HIV/AIDS Rep       Date:  2005-02       Impact factor: 5.071

3.  Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors.

Authors:  Carl Grunfeld; Donald P Kotler; Donna K Arnett; Julian M Falutz; Steven M Haffner; Paul Hruz; Henry Masur; James B Meigs; Kathleen Mulligan; Peter Reiss; Katherine Samaras
Journal:  Circulation       Date:  2008-06-19       Impact factor: 29.690

Review 4.  Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

Authors:  G M Behrens; M Stoll; R E Schmidt
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

5.  The Effects of HIV Protease Inhibitors on Carbohydrate and Lipid Metabolism.

Authors:  Grace A Lee; Madhu N Rao; Carl Grunfeld
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

Review 6.  Evaluation and management of dyslipidemia in patients with HIV infection.

Authors:  Michael L Green
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.